Cherry Hill Sales Recalls Hemorrhoidal Cream Due to Manufacturing Deviations
Cherry Hill Sales Co. is voluntarily recalling 3,600 cartons of MakeSense Hemorrhoidal Relief Cream due to CGMP deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a temporary or medically reversible adverse health consequence. The source cites CGMP deviations without reporting specific injuries or illnesses, aligning with a Moderate severity rating for a voluntary precautionary recall.
Plain-English summary
Cherry Hill Sales Co. is voluntarily recalling 3,600 cartons of MakeSense PHARMA Hemorrhoidal Relief Cream. The product is a 1 oz (28 g) tube containing Phenylephrine HCL-0.25% and Zinc Oxide-12.50%. The recall was initiated on January 27, 2017, and was classified as Class II by the FDA.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The affected lots are #103811 (Exp. 09/17) and #105304 (Exp. 04/18). The product was distributed in Michigan, Illinois, New York, Florida, and Pennsylvania. The recall status is Terminated as of April 19, 2017.
Consumers who have this product should stop using it and contact the recalling firm for instructions. The recall was initiated by the firm and notified via telephone.
The recalled product
- Product
- MakeSense PHARMA, HEMORRHOIDAL RELIEF CREAM Phenylephrine HCL-0.25% Zinc Oxide-12.50%,1 oz. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-205-28
- Manufacturer
- Cherry Hill Sales Co.
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 3,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #103811
- Exp. 09/17 Lot #105304
- Exp. 04/18 NDC 69020-205-28 UPC 857181005108
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cherry Hill Sales Co.
See all →- ModerateCherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Medicated Anti-Itch Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Clotrimazole Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls MakeSense First Aid Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
Same hazard · cgmp deviations
See all →- SevereBaxter Recalls Famotidine Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Dexmedetomidine Hydrochloride Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Nexterone Amiodarone Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateBaxter Recalls Pantoprazole Sodium Infusion Bags Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateSinus Relief Headache/Nasal Drug Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- ModerateCold Relief Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-09
- ModerateHelix Pain Relieving Cream recalled nationwide for manufacturing process violations
FDA (Drugs) · 2023-08-30
- ModerateCold/Sinus Medication Recalled for Manufacturing Process Violations
FDA (Drugs) · 2022-02-09
- ModerateMulti Symptom Cold Relief tablets recalled for cGMP deviations
FDA (Drugs) · 2022-02-09
- ModeratePain & Sinus Reliever tablets recalled for manufacturing deviations
FDA (Drugs) · 2022-02-09